MBX vs GILD: Which Stock is Better?
Side-by-side comparison of Mbx Biosciences Inc and Gilead Sciences Inc in 2026
MBX
Mbx Biosciences Inc
$28.00
GILD
Gilead Sciences Inc
$144.99
Key Metrics Comparison
| Metric | MBX | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.26B | $179.99B | GILD |
| P/E Ratio | 3.65 | 21.35 | MBX |
| EPS (TTM) | $7.67 | $6.79 | MBX |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze MBX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MBX or GILD a better investment?
Comparing MBX and GILD: Mbx Biosciences Inc has a market cap of $1.26B while Gilead Sciences Inc has $179.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MBX and GILD?
MBX (Mbx Biosciences Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MBX or GILD?
Based on P/E ratios, MBX trades at a lower multiple (3.7x vs 21.4x).
Which is growing faster: MBX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for MBX.
Which company is more profitable: MBX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for MBX.
Which is the larger company: MBX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $179.99B compared to $1.26B for MBX.
Should I buy MBX or GILD in 2026?
Both MBX and GILD have investment merit. MBX trades at $28.00 while GILD trades at $144.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MBX and GILD stock?
Key differences: Market Cap ($1.26B vs $179.99B), P/E Ratio (3.7x vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).